Biomarker Testing

Biomarker testing looks for specific molecules, proteins, genes, or other signals in blood, tissue, or fluid that give information about a disease. In cancer care, it helps confirm a diagnosis, predict how a tumor will behave, and match patients to the treatments most likely to work. Results come from lab analysis of a biopsy or blood sample.

Origin

The idea of measuring biological markers of disease is old, but modern biomarker testing expanded rapidly in the 2000s with advances in molecular and genetic analysis, which enabled targeted and immune-based cancer therapies.

Significance in Asbestos Context

For mesothelioma and asbestos-related cancers, biomarker testing, for markers like mesothelin, BAP1, and PD-L1, can support diagnosis, refine prognosis, and show whether targeted therapy or immunotherapy is an option. Testing needs enough tissue, so it's worth confirming sample adequacy early. The results appear in pathology and molecular reports that document the disease in detail, which can matter to a claim. Ask which biomarkers were tested and how they affect treatment.

Example Sentence

Biomarker testing on the biopsy showed loss of BAP1, supporting the mesothelioma diagnosis.

Related Terms

BAP1, Mesothelin, PD-L1, Molecular Testing, Immunohistochemistry

Notes

• Ask which biomarkers were tested and whether the results change treatment options.
• Confirm the biopsy has enough tissue for all recommended tests before more procedures.
• Keep pathology and molecular reports; they document the diagnosis and support a claim.